首页> 外国专利> Releasing different drugs from a stent after implantation comprises releasing an immediate-action drug in a rapid process and releasing a sustained-action drug in a long-term process

Releasing different drugs from a stent after implantation comprises releasing an immediate-action drug in a rapid process and releasing a sustained-action drug in a long-term process

机译:植入后从支架释放不同的药物包括在快速过程中释放即刻作用药物和在长期过程中释放持续作用药物

摘要

Releasing different drugs from a stent after implantation into a human or animal body comprises releasing an immediate-action drug (D2) in a rapid process and releasing a sustained-action drug (D1) in a long-term process. An independent claim is also included for a stent for implantation into a lumen in a human or animal body, comprising a sustained-action drug (D1) releasably held in a base layer and an immediate-action drug (D2) releasably held in an additional drug layer, where D1 is released over a longer period than D2. ACTIVITY : Vulnerary; Vasotropic; Anticoagulant; Antiinflammatory; Cytostatic; Immunosuppressant. MECHANISM OF ACTION : Integrin Antagonist; Thrombocyte Aggregation Inhibitor; Migration Inhibitor; Prolyl Hydroxylase Inhibitor; Protease C Inhibitor.
机译:植入人体或动物体内后,从支架上释放不同的药物包括在快速过程中释放即刻作用药物(D2)和在长期过程中释放持续作用药物(D1)。还包括用于植入人或动物体内腔的支架的独立权利要求,其包括可释放地保持在基础层中的持续作用药物(D1)和可释放地保持在另外一层中的速效药物(D2)。药物层,其中D1比D2释放的时间更长。活动:易受伤害;变压性抗凝物;消炎(药;细胞抑制免疫抑制剂。作用机理:整联蛋白拮抗剂;血小板聚集抑制剂迁移抑制剂脯氨酰羟化酶抑制剂;蛋白酶C抑制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号